OpenEvidence's mission is to organize and expand the world's collective medical knowledge. OpenEvidence's first product, its eponymous copilot for doctors that helps them make high stakes decisions at the point of care, is now used by hundreds of thousands of logged-in, verified doctors at 10,000+ care centers across the United States. Launched in 2023, OpenEvidence became the fastest platform in the history of the medical industry to surpass 100,000 verified doctor users in the United States.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/20/25 | undisclosed | Series A |
Sequoia Capital | $1,000,000,000 |
